Truist Financial Issues Positive Forecast for AdaptHealth (NASDAQ:AHCO) Stock Price

AdaptHealth (NASDAQ:AHCO) had its target price upped by Truist Financial from $12.00 to $14.00 in a report released on Wednesday morning,Benzinga reports. Truist Financial currently has a buy rating on the stock.

Several other research analysts have also commented on AHCO. Robert W. Baird reduced their price target on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday, November 6th. Canaccord Genuity Group reduced their target price on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Royal Bank of Canada lowered their price target on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a report on Tuesday, November 19th. Finally, UBS Group cut their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $13.40.

AdaptHealth Stock Performance

Shares of NASDAQ:AHCO opened at $11.10 on Wednesday. The firm has a 50 day moving average of $9.87 and a 200 day moving average of $10.21. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The company has a market capitalization of $1.49 billion, a price-to-earnings ratio of -6.73, a price-to-earnings-growth ratio of 1.08 and a beta of 1.12. AdaptHealth has a 52 week low of $8.35 and a 52 week high of $11.90.

Institutional Investors Weigh In On AdaptHealth

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AHCO. Pacer Advisors Inc. purchased a new stake in shares of AdaptHealth during the fourth quarter worth about $76,271,000. Principal Financial Group Inc. boosted its stake in AdaptHealth by 204.0% in the 4th quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company’s stock worth $15,735,000 after purchasing an additional 1,109,021 shares in the last quarter. Segall Bryant & Hamill LLC grew its position in AdaptHealth by 29.8% during the 4th quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company’s stock worth $45,734,000 after purchasing an additional 1,102,173 shares during the last quarter. State Street Corp increased its stake in AdaptHealth by 19.8% during the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock valued at $46,316,000 after purchasing an additional 681,816 shares in the last quarter. Finally, FMR LLC raised its holdings in shares of AdaptHealth by 9.3% in the third quarter. FMR LLC now owns 7,350,549 shares of the company’s stock worth $82,547,000 after buying an additional 624,645 shares during the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.